Management of osteoporosis in the elderly

Current Medical Research and Opinion

Volumn 25, Issue 10, 2009, Pages 2373-2387

  Rizzoli, René ^a   Bruyere, O ^b   Cannata Andia, J B ^c   Devogelaer, J P ^d   Lyritis, G ^e   Ringe, J D ^f   Vellas, B ^g   Reginster, J Y ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITY OF ATHENS   (Greece)

^f UNIVERSITY OF COLOGNE   (Germany)

^g UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Bisphosphonate; Falls; Frailty; Hip fracture; Osteoporosis; Strontium ranelate; Vitamin D supplementation

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; STRONTIUM RANELATE; VITAMIN D;

BONE STRENGTH; EXERCISE; FALL RISK; HIP FRACTURE; HOSPITALIZATION; HUMAN; MEDLINE; NOTE; OSTEOPOROSIS; PATIENT COMPLIANCE; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; EVIDENCE-BASED MEDICINE; EXERCISE; FRACTURES, BONE; FRAIL ELDERLY; HUMANS; OSTEOPOROSIS; POSTURAL BALANCE; RISK FACTORS;

EID: 70349335692     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903169262     Document Type: Note

References (165)

1. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465-475
2. Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 2004;15:897-902 (Pubitemid 39506456)
3. Haleem S, Lutchman L, Mayahi R, et al. Mortality following hip fracture: trends and geographical variations over the last 40 years. Injury 2008;39:1157-1163
4. Abrahamsen B, van Staa T, Ariely R, et al. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 2009 May 7 [Epub ahead of print]
5. Maravic M, Le Bihan C, Landais P, et al. Incidence and cost of osteoporotic fractures in France during 2001: a methodological approach by the national hospital database. Osteoporos Int 2005;16:1475-1480
6. Morosano M, Masoni A, Sánchez A. Incidence of hip fractures in the city of Rosario, Argentina. Osteoporos Int 2005;16:1339-1344 (Pubitemid 41532086)
7. Cummings SR, Melton 3rd LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-1767
8. Chang KP, Center JR, Nguyen TV, et al. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 2004;19:532-536
9. Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab 2008;22:671-685
10. Couris CM, Ducios A, Rabilloud M, et al. A seventy percent overestimation of the burden of hip fractures in women aged 85 and over. Bone 2007;41:896-900 (Pubitemid 47593008)
11. Seeman E, Vellas B, Benhamou C, et al. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 2006;21:1113-1120 (Pubitemid 43962840)
12. Chevalley T, Guilley E, Herrmann FR, et al. Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone 2007;40:1284-1289
13. Holt G, Smith R, Duncan K, et al. Epidemiology and outcome after hip fracture in the under 65s - evidence form the Scottish Hip Fracture Audit. Injury Int J Care Injured 2008;39:1175-1181
14. Melton 3rd LJ, Kearns AE, Atkinson EJ, et al. Secular trends in hip fracture incidence and occurrence. Osteoporos Int 2009;20:687-694
15. Berry SD, Samelson EJ, Hannan MT, et al. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med 2007;167:1971-1976 (Pubitemid 47606637)
16. Ryg J, Rejnmark L, Overgaard S, et al. Hip fracture patients at risk of second hip fracture - a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res 2009;24:1299-1307
17. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001;12:989-995 (Pubitemid 34105967)
18. Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004;34:195-202 (Pubitemid 38142449)
19. Wainwright SA, Marshall LM, Ensrud KE, et al.; Study of Osteoporotic Fractures Research Group. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005;90:2787-2793
20. Sanders KM, Nicholson GC, Watts JJ, et al. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Bone 2006;38:694-700
21. Järvinen TL, Sievänen H, Khan KM, et al. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ 2008;336:124-126 (Pubitemid 351211962)
22. Parkkari J, Kannus P, Palvanen M, et al. Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int 1999;65:183-187 (Pubitemid 29380335)
23. Youm T, Koval KJ, Kummer FJ, et al. Do all hip fractures result from a fall? Am J Orthop 1999;28:190-194
24. Cooper C, Atkinson EJ, O'Fallon WM, et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992;7:221-227
25. Birge SJ. Osteoporotic fractures: a brain or bone disease? Curr Osteoporos Rep 2008;6:57-61
26. Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm - issues and controversies. J Gerontol A Biol Sci Med Sci 2007;62:731-737 (Pubitemid 350143604)
27. Fried LP, Tangen CM, Walston J, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-M156
28. Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004;59:255-263 (Pubitemid 38375339)
29. Boyd CM, Xue QL, Simpson CF, et al. Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med 2005;118:1225-1231
30. Woods NF, LaCroix AZ, Gray SL; Women's Health Initiative. J Am Geriatr Soc 2005;53:1321-1330
31. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci 2006;61:262-266
32. Cawthon PM, Marshall LM, Michael Y, et al.; Osteoporotic Fractures in Men Research Group. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 2007;55:1216-1223
33. Ensrud KE, Ewing SK, Taylor BC, et al.; for the Study of Osteoporotic Fractures Research Group. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2007;62:744-751
34. Avila-Funes JA, Helmer, C, Amieva H, et al. Frailty among community-dwelling elderly people in France: the three-city study. J Gerontol A Biol Sci Med Sci 2008;63:1089-1096
35. Santos-Eggimann B, Cuénoud P, Spagnoli J, et al. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 2009;64:675-681
36. Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am Geriatr Soc 2008;56:2211-2216
37. Avila-Funes JA, Amieva H, Barberger-Gateau P, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc 2009;57:453-461
38. Ensrud KE, Ewing SK, Taylor BC, et al.; for the Study of Osteoporotic Fractures Research Group. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 2008;168:382-389
39. Wagner H, Melhus H, Gedeborg R, et al. Simply ask them about their balance - future fracture risk in a nationwide cohort study of twins. Am J Epidemiol 2009;169:143-149
40. Olofsson B, Stenvall M, LundströmM, et al. Malnutrition in hip fracture patients: an intervention study. J Clin Nurs 2007;16:2027-2038
41. Salminen H, Sääf M, Johansson SE, et al. Nutritional status, as determined by the Mini-Nutritional Assessment, and osteoporosis: a cross-sectional study of an elderly female population. Eur J Clin Nutr 2006;60:486-493
42. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006;54:991-1001 (Pubitemid 43847040)
43. Howard C, Ferrucci L, Sun K, et al. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol 2007;103:17-20 (Pubitemid 47092272)
44. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245-270
45. Ershler WB. A gripping reality: oxidative stress, inflammation, and the pathway to frailty. J Appl Physiol 2007;103:3-5
46. Leng SX, Xue QL, Tian J, et al. Inflammation and frailty in older women. J Am Geriatr Soc 2007;55:864-871
47. Puts MT, Visser M, Twisk JW, et al. Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 2005;63:403-411 (Pubitemid 41442334)
48. Walston J, Fedarko N, Yang H, et al. The physical and biological characterization of a frail mouse model. J Gerontol A Biol Sci Med Sci 2008;63:391-398 (Pubitemid 351738421)
49. Gill TM, Gahbauer EA, Allore HG, et al. Transitions between frailty states among community-living older persons. Arch Intern Med 2006;166:418-423 (Pubitemid 43313645)
50. Kannus P, Sievänen H, Palvanen M, et al. Prevention of falls and consequent injuries in elderly people. Lancet 2005;366:1885-1893 (Pubitemid 41690118)
51. O'Loughlin JL, Robitaille Y, Boivin JF, et al. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993;137:342-354 (Pubitemid 23090468)
52. Vellas BJ, Wayne SJ, Garry PJ, et al. A two-year longitudinal study of falls in 482 community-dwelling elderly adults. J Gerontol A Biol Sci Med Sci 1998;53:M264-M274
53. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. Guideline for the prevention of falls in older persons. J Am Geriatr Soc 2001;49:664-672
54. Rao SS. Prevention of falls in older patients. Am Fam Physician 2005;72:81-88
55. Stevens JA, Mack KA, Paulozzi LJ, et al. Self-reported falls and fall-related injuries among persons aged ≥65 years - United States, 2006. J Safety Res 2008;39:345-349
56. Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 1997;337:1279-1284
57. Sattin RW, Lambert Huber DA, DeVito CA, et al. The incidence of fall injury events among the elderly in a defined population. Am J Epidemiol 1990;131:1028-1037
58. Kannus P, Parkkari J, Koskinen S, et al. Fall-induced injuries and deaths among older adults. JAMA 1999;281:1895-1899 (Pubitemid 29242802)
59. Winner SJ, Morgan CA, Evans JG. Perimenopausal risk of falling and incidence of distal forearm fracture. BMJ 1989;298:1486-1488
60. Davies JC, Stevens G, Manning DP. An investigation of underfoot accidents in a MAIM (Merseyside Accident Information Model) database. Appl Ergon 2001;32:141-147
61. Davies JC Manning DP, Kemp GJ, et al. The rising number of underfoot accidents after the menopause causes both fractures and non-fracture injuries. QJ Med 2001;94:699-707
62. Scuffham P, Chaplin S, Legood R. Incidence and costs of unintentional falls in older people in the United Kingdom. J Epidemiol Community Health 2003;57:740-744 (Pubitemid 37059646)
63. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999;47:30-39
64. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999;47:40-50 (Pubitemid 29044265)
65. Landi F, Onder G, Cesari M, et al.; Silver Network Home Care Study Group. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005;60:622-626
66. Rubenstein LZ. Falls in older people: epidemiology, risk factors and strategies for prevention. Age Ageing 2006;35 (Suppl. 2):ii37-ii41
67. Gates S, Fisher JD, Cooke MW, et al. Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis. BMJ 2008;336:130-133 (Pubitemid 351211964)
68. Gillespie LD, Gillespie WJ, Robertson MC, et al. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2003;2:CD000340
69. Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009;2:CD007146
70. Close J, Ellis M, Hooper R, et al. Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. Lancet 1999;353:93-97 (Pubitemid 29088077)
71. Hendriks MR, Bleijlevens MH, van Haastregt JC, et al. Lack of effectiveness of a multidisciplinary fall-prevention program in elderly people at risk: a randomized, controlled trial. J Am Geriatr Soc 2008;56:1390-1397
72. Lin MR, Wolf SL, Hwang HF, et al. A randomized, controlled trial of fall prevention programs and quality of life in older fallers. J Am Geriatr Soc 2007;55:499-506
73. Sherrington C, Whitney JC, Lord SR, et al. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc 2008;56:2234-2243
74. Bérard A, Bravo G, Gauthier P. Meta-analysis of the effectiveness of physical activity for the prevention of bone loss in postmenopausal women. Osteoporos Int 1997;7:331-337 (Pubitemid 27346413)
75. Wolff I, van Croonenborg JJ, Kemper HC, et al. The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 1999;9:1-12 (Pubitemid 29086158)
76. Shea B, Bonaiuti D, Iovine R, et al. Cochrane Review on exercise for preventing and treating osteoporosis in postmenopausal women. Eura Medicophys 2004;40:199-209 (Pubitemid 39424578)
77. Murphy MH, Nevill AM, Murtagh EM, et al. The effect of walking on fitness, fatness and resting blood pressure: a meta-analysis of randomised, controlled trials. Prev Med 2007;44:377-385
78. Li F, Harmer P, Fisher KJ, et al. Tai Chi and fall reductions in older adults: a randomised controlled trial. J Gerontol A Biol Sci Med Sci 2005;60:187-194 (Pubitemid 40524858)
79. Robertson MC, Campbell AJ, Gardner MM, et al. Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. J Am Geriatr Soc 2002;50:905-911 (Pubitemid 34496689)
80. Delecluse C, Roelants M, Verschueren S. Strength increase after whole-body vibration compared with resistance training. Med Sci Sports Exerc 2003;35:1033-1041 (Pubitemid 36706293)
81. Verschueren SM, Roelants M, Delecluse C, et al. Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study. J Bone Miner Res 2004;19:352-359 (Pubitemid 38787389)
82. Bautmans I, Van Hees E, Lemper JC, et al. The feasibility of Whole Body Vibration in institutionalised elderly persons and its influence on muscle performance, balance and mobility: a randomised controlled trial [ISRCTN62535013]. BMC Geriatr 2005;5:17 (Pubitemid 43273977)
83. Bruyère O, Wuidart MA, Di Palma E, et al. Controlled whole body vibration to decrease fall risk and improve health-related quality of life of nursing home residents. Arch Phys Med Rehabil 2005;86:303-307 (Pubitemid 40215294)
84. Parker MJ, Gillespie WJ, Gillespie LD. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 2005;3:CD001255
85. Parker MJ, Gillespie WJ, Gillespie LD. Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ 2006;332:571-574
86. Kiel DP, Magaziner J, Zimmerman S, et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA 2007;298:413-422 (Pubitemid 47124062)
87. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-373 (Pubitemid 43334631)
88. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92:4-8
89. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986;7:434-448
90. Visser M, Deeg DJ, Lips P; Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2002;88:5766-5772
91. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥65 y. Am J Clin Nutr 2004;80:752-758 (Pubitemid 41115542)
92. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008;29:407-414
93. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536-1538 (Pubitemid 16193572)
94. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fracture. Ann Intern Med 2008;149:242-250
95. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28 (Pubitemid 44699167)
96. Gómez-Alonso C, Naves-Diaz M, Fernández-Martin JL. Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl 2003;85:S44-S48
97. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-716
98. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005;97:13-19
99. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212-1221 (Pubitemid 32323007)
100. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215-3224 (Pubitemid 41014278)
101. Reginster JY. The high prevalence of inadequate serum vitamin D levels and implications for bone health. Curr Med Res Opin 2005;21:579-586
102. Rizzoli R, Eisman JA, Norquist J, et al. Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study. Int J Clin Pract 2006;60:1013-1019 (Pubitemid 44082295)
103. Kiebzak GM, Moore NL, Margolis S, et al. Vitamin D status of patients admitted to a hospital rehabilitation unit: relationship to function and progress. Am J Phys Med Rehabil 2007;86:435-445 (Pubitemid 46791498)
104. Neuprez A, Bruyère O, Collette J, et al. Vitamin D inadequacy in Belgian postmenopausal osteoporotic women. BMC Public Health 2007;7:64
105. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanlysis of randomized controlled trials. J Clin Endocrinol Metab 2007;92:1415-1423 (Pubitemid 46556419)
106. Rizzoli R, Boonen S, Brandi ML, et al. The role of calcium and vitamin D in the management of osteoporosis. Bone 2008;42:246-249
107. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-1642
108. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-2264 (Pubitemid 40629192)
109. Jackson RD, LaCroix AZ, Gass M, et al.; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-683
110. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370:657-666 (Pubitemid 47285316)
111. Avenell A, Gillespie WJ, Gillespie LD, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009;2:CD000227
112. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006
113. Sem SW, Sjøen RJ, Trygg K, et al. Vitamin D status of two groups of elderly in Oslo: living in old people's homes and living in own homes. Compr Gerontol [A] 1987;1:126-130
114. Kinyamu HK, Gallagher JC, Balhorn KE, et al. Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes. Am J Clin Nutr 1997;65:790-797 (Pubitemid 27111087)
115. Lappe JM, Davies KM, Travers-Gustafson D, et al. Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr 2006;25:395-402 (Pubitemid 44522576)
116. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008;336:262-266
117. Segal E, Zinman C, Raz B, et al. Low patient compliance - a major negative factor in achieving vitamin D adequacy in elderly hip fracture patients supplemented with 800 IU of vitamin D3 daily. Arch Gerontol Geriatr 2009 Jan 13 [Epub ahead of print]
118. Petrella RJ, Jones TJ. Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Fam Pract 2006;7:31
119. Rossini M, Bianchi G, Di Munno O, et al.; Treatment of Osteoporosis in clinical Practice (TOP) Study Group. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 2006;17:914-921
120. Grant AM, Avenell A, Campbell MK, et al.; RECORD Trial Group. Oral vitamin D2 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-1628
121. Ringe JD, van der Geest SA, Möller G. Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence. Drugs Aging 2006;23:569-578 (Pubitemid 44310548)
122. Ringe JD, Fardellone P, Kruse HP, et al. Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studies. Drugs Aging 2009;26:241-253
123. Boonen S, Laan RF, Barton IP, et al. Effect of osteoporosis treatments on the risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. Osteoporos Int 2005;16:1291-1298 (Pubitemid 41396959)
124. Freedman KB, Kaplan FS, Bilker WB, et al. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am 2000;82A:1063-1070
125. Gehlbach SH, Bigelow C, Heimisdottir M, et al. Recognition of vertebral fracture in a clinical setting. Osteoporos Int 2000;11:577-582 (Pubitemid 30739880)
126. Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003;163:2052-2057 (Pubitemid 37151247)
127. Elliot-Gibson V, Bogoch ER, Jamal SA, et al. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004;15:767-778 (Pubitemid 39361946)
128. Perreault S, Dragomir A, Desgagné A, et al. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf 2005;14:685-695 (Pubitemid 41489448)
129. Roerholt C, Eiken P, Abrahamsen B. Initiation of antiosteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int 2009;20:299-307
130. Rabenda V, Vanoverloop J, Fabri V, et al. Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am 2008;90:2142-2148
131. Gehlbach SH, Avrunin JS, Pulco E, et al. Fracture risk and antiresorptive medication use in older women in the USA. Osteoporos Int 2007;18:805-810 (Pubitemid 46684787)
132. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001;12:519-528 (Pubitemid 32777427)
133. Parikh S, Mogun H, Avorn J, et al. Osteoporosis medication use in nursing home patients with fractures in 1 US state. Arch Intern Med 2008;168:1111-1115 (Pubitemid 351749229)
134. Inderjeeth CA, Foo AC, Lai MM, et al. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence. Bone 2009;44:744-751
135. Boonen S, Dejaeger E, Vanderschueren D, et al. Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective. Best Pract Res Clin Endocrinol Metab 2008;22:765-785
136. Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004;350:459-468 (Pubitemid 38133766)
137. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005;90:2816-2822 (Pubitemid 40686329)
138. Ensrud KE, Black DM, Palermo L, et al. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med 1997;157:2617-2624 (Pubitemid 27519982)
139. Hochberg MC, Thompson DE, Black DM, et al.; the FIT Research Group. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 2005;20:971-976
140. McClung MR, Geusens P, Miller PD, et al.; the Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-340
141. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 1999;282:1344-1352
142. Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000;11:83-91 (Pubitemid 30099515)
143. Boonen S, McClung MR, Eastell R, et al. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc 2004;52:1832-1839 (Pubitemid 41710266)
144. McCloskey EV, Beneton M, Charlesworth D, et al. Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 2007;22:135-141 (Pubitemid 46032606)
145. Lyles KW, Colón-Emeric CS, Magaziner JS, et al.; HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007;357:1799-1809
146. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-1441
147. Boonen S, Marin F, Mellstrom D, et al. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc 2006;54:782-789 (Pubitemid 44030200)
148. Cramer JA, Amonkar MM, Hebborn A, et al. Compliance with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005;21:1453-1460 (Pubitemid 41368578)
149. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med 2005;165:2414-2419
150. Blouin J, Dragomir A, Ste-Marie LG, et al. Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women. J Clin Endocrinol Metab 2007;92:887-894
151. Penning-van Beest FJ, Erkens JA, Olson M, et al. Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis. Curr Med Res Opin 2008;24:1337-1344 (Pubitemid 351741565)
152. Weycker D, Macarios D, Edelsberg J, et al. Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 2006;17:1645-1652 (Pubitemid 44477625)
153. Jones TJ, Petrella RJ, Crilly R. Determinants of persistence with weekly bisphosphonates in patients with osteoporosis. J Rheumatol 2008;35:1865-1873
154. Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 2006;81:1013-1022
155. Blouin J, Dragomir A, Moride Y, et al. Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol 2008;66:117-127 (Pubitemid 351822168)
156. Penning-van Beest FJ, Erkens JA, Olson M, et al. Loss of treatment
157. Rabenda V, Mertens R, Fabri V, et al. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 2008;19:811-818
158. van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging 2003;20:229-240 (Pubitemid 36269584)
159. George J, Elliott RA, Stewart DC. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging 2009;25:307-324
160. Papaioannou A, Kennedy CC, Dolovich L, et al. Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 2007;24:37-55 (Pubitemid 46148080)
161. Brankin E, Walker M, Lynch N, et al. The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Curr Med Res Opin 2006;22:1249-1256 (Pubitemid 44085576)
162. Reginster JY, Malaise O, Neuprez A, et al. Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date. Drugs Aging 2007;24:351-359 (Pubitemid 46790260)
163. Boonen S, Vanderschueren D, Venken K, et al. Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance. J Intern Med 2008;264:315-332
164. Sunyecz J. Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations. Clin Interv Aging 2008;3:611-627
165. Black DM, Delmas PD, Eastell R, et al.; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid fro treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-1822